{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T12:38:49Z","timestamp":1648730329988},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ophthalmologe"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1007\/s00347-020-01219-x","type":"journal-article","created":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T11:02:57Z","timestamp":1598958177000},"page":"949-961","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Hornhautver\u00e4nderungen bei Liderkrankungen"],"prefix":"10.1007","volume":"117","author":[{"given":"Elisabeth M.","family":"Messmer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,9,1]]},"reference":[{"issue":"4390","key":"1219_CR1","first-page":"4390","volume":"48","author":"IK Gipson","year":"2007","unstructured":"Gipson\u00a0IK (2007) The ocular surface: the challenge to enable and protect vision: the Friedenwald lecture. Invest Ophthalmol Vis Sci 48(4390):4390\u20134398","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"1219_CR2","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1097\/IOP.0b013e3182115229","volume":"27","author":"RW Damasceno","year":"2011","unstructured":"Damasceno\u00a0RW, Osaki\u00a0MH, Dantas\u00a0PE et\u00a0al (2011) Involutional entropion and ectropion of the lower eyelid: prevalence and associated risk factors in the elderly population. Ophthal Plast Reconstr Surg 27:317\u2013320","journal-title":"Ophthal Plast Reconstr Surg"},{"key":"1219_CR3","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1136\/bjophthalmol-2011-301191","volume":"96","author":"C Lane","year":"2012","unstructured":"Lane\u00a0C (2012) Management of ocular surface exposure. Br J Ophthalmol 96:471\u2013472","journal-title":"Br J Ophthalmol"},{"key":"1219_CR4","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1097\/01.ico.0000151563.24989.f6","volume":"24","author":"ET Detorakis","year":"2005","unstructured":"Detorakis\u00a0ET, Ioannakis\u00a0K, Kozobolis\u00a0VP (2005) Corneal topography in involutional ectropion of the lower eyelid: preoperative and postoperative evaluation. Cornea 24:431\u2013434","journal-title":"Cornea"},{"key":"1219_CR5","doi-asserted-by":"crossref","first-page":"356","DOI":"10.3928\/0191-3913-20011101-10","volume":"38","author":"S Jeong","year":"2001","unstructured":"Jeong\u00a0S, Park\u00a0H, Park\u00a0YG (2001) Surgical correction of congenital epiblepharon: low eyelid crease reforming technique. J\u00a0Pediatr Ophthalmol Strabismus 38:356\u2013358","journal-title":"J Pediatr Ophthalmol Strabismus"},{"key":"1219_CR6","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.jaapos.2016.01.015","volume":"20","author":"H Lee","year":"2016","unstructured":"Lee\u00a0H, Jang\u00a0S, Park\u00a0M et al (2016) Effects of epiblepharon surgery on higher-order aberrations. J\u00a0AAPOS 20:226\u2013231","journal-title":"J AAPOS"},{"key":"1219_CR7","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1055\/s-2005-858455","volume":"222","author":"A Heiligenhaus","year":"2005","unstructured":"Heiligenhaus\u00a0A, Bonsmann\u00a0G, Heinz\u00a0C et\u00a0al (2005) Diagnostic and therapeutic recommendations for mucous membrane pemphigoid of the eye. Klin Monatsbl Augenheilkd 222:689\u2013703","journal-title":"Klin Monatsbl Augenheilkd"},{"key":"1219_CR8","first-page":"399","volume":"108","author":"E Schmidt","year":"2011","unstructured":"Schmidt\u00a0E, Zillikens\u00a0D (2011) The diagnosis and treatment of autoimmune blistering skin diseases. Dtsch Arztebl Int 108:399\u2013405, i\u2013iii","journal-title":"Dtsch Arztebl Int"},{"key":"1219_CR9","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.ophtha.2017.10.004","volume":"125","author":"HS Ong","year":"2018","unstructured":"Ong\u00a0HS, Setterfield\u00a0JF, Minassian\u00a0DC et\u00a0al (2018) Mucous membrane pemphigoid with ocular involvement: the clinical phenotype and its relationship to direct Immunofluorescence findings. Ophthalmology 125:496\u2013504","journal-title":"Ophthalmology"},{"key":"1219_CR10","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1097\/00003226-199401000-00007","volume":"13","author":"WW Culbertson","year":"1994","unstructured":"Culbertson\u00a0WW, Tseng\u00a0SC (1994) Corneal disorders in floppy eyelid syndrome. Cornea 13:33\u201342","journal-title":"Cornea"},{"key":"1219_CR11","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1007\/s00347-019-00985-7","volume":"116","author":"U L\u00f6w","year":"2019","unstructured":"L\u00f6w\u00a0U, Schie\u00dfl\u00a0G, Spira-Eppig\u00a0C et al (2019) Floppy eyelid syndrome : A frequently underdiagnosed entity of interdisciplinary importance. Ophthalmologe 116:1091\u20131102","journal-title":"Ophthalmologe"},{"key":"1219_CR12","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jtos.2019.10.002","volume":"18","author":"R Salinas","year":"2020","unstructured":"Salinas\u00a0R, Puig\u00a0M, Fry\u00a0CL et\u00a0al (2020) Floppy eyelid syndrome: a comprehensive review. Ocul Surf 18:31\u201339","journal-title":"Ocul Surf"},{"key":"1219_CR13","doi-asserted-by":"crossref","first-page":"e81","DOI":"10.1097\/IJG.0b013e31829da19f","volume":"23","author":"M Muniesa","year":"2014","unstructured":"Muniesa\u00a0M, Sanchez-De-La-Torre\u00a0M, Huerva\u00a0V et al (2014) Floppy eyelid syndrome as an indicator of the presence of glaucoma in patients with obstructive sleep apnea. J\u00a0Glaucoma 23:e81\u201385","journal-title":"J Glaucoma"},{"key":"1219_CR14","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1097\/ICO.0000000000000396","volume":"34","author":"M Muniesa","year":"2015","unstructured":"Muniesa\u00a0M, March\u00a0A, Sanchez-De-La-Torre\u00a0M et al (2015) Corneal biomechanical properties in floppy eyelid syndrome. Cornea 34:521\u2013524","journal-title":"Cornea"},{"key":"1219_CR15","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1097\/ICO.0b013e318281e755","volume":"32","author":"MS Pihlblad","year":"2013","unstructured":"Pihlblad\u00a0MS, Schaefer\u00a0DP (2013) Eyelid laxity, obesity, and obstructive sleep apnea in keratoconus. Cornea 32:1232\u20131236","journal-title":"Cornea"},{"key":"1219_CR16","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1016\/j.jcrs.2014.07.014","volume":"40","author":"GD Kymionis","year":"2014","unstructured":"Kymionis\u00a0GD, Grentzelos\u00a0MA, Liakopoulos\u00a0DA et\u00a0al (2014) Corneal collagen crosslinking failure in a\u00a0patient with floppy eyelid syndrome. J\u00a0Cataract Refract Surg 40:1558\u20131560","journal-title":"J Cataract Refract Surg"},{"key":"1219_CR17","first-page":"223","volume":"13","author":"P Imbert","year":"1990","unstructured":"Imbert\u00a0P, Williamson\u00a0W, Leger\u00a0F et\u00a0al (1990) Bilateral corneal neovascularization and floppy eyelid syndrome. A case report. J\u00a0Francais Ophtalmol 13:223\u2013225","journal-title":"J Francais Ophtalmol"},{"key":"1219_CR18","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1167\/iovs.04-0913","volume":"46","author":"DT Liu","year":"2005","unstructured":"Liu\u00a0DT, Di Pascuale\u00a0MA, Sawai\u00a0J et\u00a0al (2005) Tear film dynamics in floppy eyelid syndrome. Invest Ophthalmol Vis Sci 46:1188\u20131194","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"1219_CR19","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1016\/S0161-6420(99)90256-7","volume":"106","author":"DS Mojon","year":"1999","unstructured":"Mojon\u00a0DS, Goldblum\u00a0D, Fleischhauer\u00a0J et\u00a0al (1999) Eyelid, conjunctival, and corneal findings in sleep apnea syndrome. Ophthalmology 106:1182\u20131185","journal-title":"Ophthalmology"},{"key":"1219_CR20","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1007\/s00347-017-0604-x","volume":"114","author":"F Lang","year":"2017","unstructured":"Lang\u00a0F, Press\u00a0UP (2017) Infantile hemangioma of the eyelid. Ophthalmologe 114:1171\u20131180","journal-title":"Ophthalmologe"},{"key":"1219_CR21","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1136\/bjo.75.5.301","volume":"75","author":"AJ Morrell","year":"1991","unstructured":"Morrell\u00a0AJ, Willshaw\u00a0HE (1991) Normalisation of refractive error after steroid injection for adnexal haemangiomas. Br J Ophthalmol 75:301\u2013305","journal-title":"Br J Ophthalmol"},{"key":"1219_CR22","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1038\/eye.2011.233","volume":"25","author":"M Snir","year":"2011","unstructured":"Snir\u00a0M, Reich\u00a0U, Siegel\u00a0R et\u00a0al (2011) Refractive and structural changes in infantile periocular capillary haemangioma treated with propranolol. Eye 25:1627\u20131634","journal-title":"Eye"},{"key":"1219_CR23","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1136\/bjo.5.3.117","volume":"5","author":"AW Ormond","year":"1921","unstructured":"Ormond\u00a0AW (1921) Notes on three cases of acquired astigmatism associated with meibomian cysts. Br J Ophthalmol 5:117\u2013118","journal-title":"Br J Ophthalmol"},{"key":"1219_CR24","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1177\/112067210901900401","volume":"19","author":"A Bagheri","year":"2009","unstructured":"Bagheri\u00a0A, Hasani\u00a0HR, Karimian\u00a0F et\u00a0al (2009) Effect of chalazion excision on refractive error and corneal topography. Eur J Ophthalmol 19:521\u2013526","journal-title":"Eur J Ophthalmol"},{"key":"1219_CR25","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.2147\/OPTH.S133060","volume":"11","author":"S Fukuoka","year":"2017","unstructured":"Fukuoka\u00a0S, Arita\u00a0R, Shirakawa\u00a0R et al (2017) Changes in meibomian gland morphology and ocular higher-order aberrations in eyes with chalazion. Clin Ophthalmol 11:1031\u20131038","journal-title":"Clin Ophthalmol"},{"key":"1219_CR26","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s12886-017-0426-2","volume":"17","author":"KW Jin","year":"2017","unstructured":"Jin\u00a0KW, Shin\u00a0YJ, Hyon\u00a0JY (2017) Effects of chalazia on corneal astigmatism : large-sized chalazia in middle upper eyelids compress the cornea and induce the corneal astigmatism. BMC Ophthalmol 17:36","journal-title":"BMC Ophthalmol"},{"key":"1219_CR27","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1097\/ICO.0b013e318268d6b3","volume":"32","author":"AA Sabermoghaddam","year":"2013","unstructured":"Sabermoghaddam\u00a0AA, Zarei-Ghanavati\u00a0S, Abrishami\u00a0M (2013) Effects of chalazion excision on ocular aberrations. Cornea 32:757\u2013760","journal-title":"Cornea"},{"key":"1219_CR28","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1007\/s00347-018-0837-3","volume":"116","author":"G Geerling","year":"2019","unstructured":"Geerling\u00a0G (2019) Neurotrophic keratopathy-Underdiagnosed and incurable? Ophthalmologe 116:108","journal-title":"Ophthalmologe"},{"key":"1219_CR29","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.ophtha.2007.10.009","volume":"115","author":"TJ Liesegang","year":"2008","unstructured":"Liesegang\u00a0TJ (2008) Herpes zoster ophthalmicus natural history, risk factors, clinical presentation, and morbidity. Ophthalmology 115:S3\u2013S12","journal-title":"Ophthalmology"},{"key":"1219_CR30","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1097\/01.icu.0000143686.68103.46","volume":"15","author":"TJ Liesegang","year":"2004","unstructured":"Liesegang\u00a0TJ (2004) Herpes zoster virus infection. Curr Opin Ophthalmol 15:531\u2013536","journal-title":"Curr Opin Ophthalmol"},{"key":"1219_CR31","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1055\/s-0029-1245329","volume":"227","author":"M Roesel","year":"2010","unstructured":"Roesel\u00a0M, Heiligenhaus\u00a0A, Messmer\u00a0EM (2010) Clinical presentation of zoster ophthalmicus. Klin Monatsbl Augenheilkd 227:370\u2013374","journal-title":"Klin Monatsbl Augenheilkd"},{"key":"1219_CR32","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1007\/s00347-017-0562-3","volume":"114","author":"RN Werner","year":"2017","unstructured":"Werner\u00a0RN, Steinhorst\u00a0NI, Nast\u00a0A et\u00a0al (2017) Diagnostics and management of herpes zoster ophthalmicus. Ophthalmologe 114:959\u2013972","journal-title":"Ophthalmologe"},{"key":"1219_CR33","first-page":"563","volume":"15","author":"F Butsch","year":"2017","unstructured":"Butsch\u00a0F, Greger\u00a0D, Butsch\u00a0C et al (2017) Die prognostische Bedeutung des Hutchinson-Zeichens f\u00fcr eine okul\u00e4re Beteiliung bei Herpes zoster ophtalmicus. J\u00a0Dtsch Dermatol Ges 15:563\u2013564","journal-title":"J Dtsch Dermatol Ges"},{"key":"1219_CR34","doi-asserted-by":"crossref","first-page":"195","DOI":"10.3109\/02713688709020090","volume":"6","author":"M Cobo","year":"1987","unstructured":"Cobo\u00a0M, Foulks\u00a0GN, Liesegang\u00a0T et\u00a0al (1987) Observations on the natural history of herpes zoster ophthalmicus. Curr Eye Res 6:195\u2013199","journal-title":"Curr Eye Res"},{"key":"1219_CR35","first-page":"55","volume":"18","author":"GE Gross","year":"2020","unstructured":"Gross\u00a0GE, Eisert\u00a0L, Doerr\u00a0HW et\u00a0al (2020) S2k guidelines for the diagnosis and treatment of herpes zoster and postherpetic neuralgia. J\u00a0Dtsch Dermatol Ges 18:55\u201378","journal-title":"J Dtsch Dermatol Ges"},{"key":"1219_CR36","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1016\/j.ophtha.2016.03.005","volume":"123","author":"KD Tran","year":"2016","unstructured":"Tran\u00a0KD, Falcone\u00a0MM, Choi\u00a0DS et\u00a0al (2016) Epidemiology of herpes zoster ophthalmicus: recurrence and chronicity. Ophthalmology 123:1469\u20131475","journal-title":"Ophthalmology"},{"key":"1219_CR37","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1007\/s00103-019-02882-5","volume":"62","author":"A Siedler","year":"2019","unstructured":"Siedler\u00a0A, Koch\u00a0J, Garbe\u00a0E et\u00a0al (2019) Background paper to the decision to recommend the vaccination with the inactivated herpes zoster subunit vaccine: Statement of the German Standing Committee on Vaccination (STIKO) at the Robert Koch\u00a0Institute. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 62:352\u2013376","journal-title":"Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz"},{"key":"1219_CR38","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0939-6411(01)00246-6","volume":"53","author":"P Furrer","year":"2002","unstructured":"Furrer\u00a0P, Mayer\u00a0JM, Gurny\u00a0R (2002) Ocular tolerance of preservatives and alternatives. Eur J Pharm Biopharm 53:263\u2013280","journal-title":"Eur J Pharm Biopharm"},{"key":"1219_CR39","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1097\/ACI.0b013e3283306990","volume":"9","author":"J Hong","year":"2009","unstructured":"Hong\u00a0J, Bielory\u00a0L (2009) Allergy to ophthalmic preservatives. Curr Opin Allergy Clin Immunol 9:447\u2013453","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"1219_CR40","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1111\/j.0105-1873.2006.0645b.x","volume":"54","author":"M Kalavala","year":"2006","unstructured":"Kalavala\u00a0M, Statham\u00a0BN (2006) Allergic contact dermatitis from timolol and dorzolamide eye drops. Contact Derm 54:345","journal-title":"Contact Derm"},{"key":"1219_CR41","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1034\/j.1600-0536.2002.460510.x","volume":"46","author":"M Corazza","year":"2002","unstructured":"Corazza\u00a0M, Levratti\u00a0A, Zampino\u00a0MR et\u00a0al (2002) Conventional patch tests are poor detectors of contact allergy from ophthalmic products. Contact Derm 46:298\u2013299","journal-title":"Contact Derm"},{"key":"1219_CR42","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1080\/00015550410024102","volume":"85","author":"M Corazza","year":"2005","unstructured":"Corazza\u00a0M, Masieri\u00a0LT, Virgili\u00a0A (2005) Doubtful value of patch testing for suspected contact allergy to ophthalmic products. Acta Derm Venereol 85:70\u201371","journal-title":"Acta Derm Venereol"},{"key":"1219_CR43","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/all.12986","volume":"72","author":"JL Fauquert","year":"2017","unstructured":"Fauquert\u00a0JL, Jedrzejczak-Czechowicz\u00a0M, Rondon\u00a0C et al (2017) Conjunctival allergen provocation test : guidelines for daily practice. Allergy 72:43\u201354","journal-title":"Allergy"},{"key":"1219_CR44","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/S0002-9394(02)01726-9","volume":"134","author":"EM Messmer","year":"2002","unstructured":"Messmer\u00a0EM, May\u00a0CA, Stefani\u00a0FH et\u00a0al (2002) Toxic eosinophil granule protein deposition in corneal ulcerations and scars associated with atopic keratoconjunctivitis. Am J Ophthalmol 134:816\u2013821","journal-title":"Am J Ophthalmol"},{"key":"1219_CR45","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1001\/jamaophthalmol.2013.6277","volume":"132","author":"DS Borkar","year":"2014","unstructured":"Borkar\u00a0DS, Gonzales\u00a0JA, Tham\u00a0VM et\u00a0al (2014) Association between atopy and herpetic eye disease: results from the pacific ocular inflammation study. JAMA Ophthalmol 132:326\u2013331","journal-title":"JAMA Ophthalmol"},{"key":"1219_CR46","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1007\/s00347-003-0809-z","volume":"100","author":"C Kallen","year":"2003","unstructured":"Kallen\u00a0C, Reinhard\u00a0T, Schilgen\u00a0G et\u00a0al (2003) Atopic keratoconjunctivitis: probably a\u00a0risk factor for the development of conjuntival carcinoma. Ophthalmologe 100:808\u2013814","journal-title":"Ophthalmologe"},{"key":"1219_CR47","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1159\/000448220","volume":"3","author":"A Shah","year":"2017","unstructured":"Shah\u00a0A, Espana\u00a0EM, Singh\u00a0AD (2017) Ocular surface squamous neoplasia associated with atopic keratoconjunctivitis. Ocul Oncol Pathol 3:22\u201327","journal-title":"Ocul Oncol Pathol"},{"key":"1219_CR48","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1136\/bjo.84.8.834","volume":"84","author":"AM Bawazeer","year":"2000","unstructured":"Bawazeer\u00a0AM, Hodge\u00a0WG, Lorimer\u00a0B (2000) Atopy and keratoconus: a\u00a0multivariate analysis. Br J Ophthalmol 84:834\u2013836","journal-title":"Br J Ophthalmol"},{"key":"1219_CR49","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1097\/ICO.0000000000002150","volume":"39","author":"H Hashemi","year":"2020","unstructured":"Hashemi\u00a0H, Heydarian\u00a0S, Hooshmand\u00a0E et al (2020) The prevalence and risk factors for keratoconus: a systematic review and meta-analysis. Cornea 39:263\u2013270","journal-title":"Cornea"},{"key":"1219_CR50","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1038\/sj.eye.6702692","volume":"22","author":"KH Weed","year":"2008","unstructured":"Weed\u00a0KH, Macewen\u00a0CJ, Giles\u00a0T et\u00a0al (2008) The Dundee University Scottish Keratoconus study: demographics, corneal signs, associated diseases, and eye rubbing. Eye 22:534\u2013541","journal-title":"Eye"},{"key":"1219_CR51","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1097\/ICO.0b013e31816f6328","volume":"27","author":"N Ebihara","year":"2008","unstructured":"Ebihara\u00a0N, Funaki\u00a0T, Matsuda\u00a0H et\u00a0al (2008) Corneal abnormalities in the NC\/Nga mouse: an atopic dermatitis model. Cornea 27:923\u2013929","journal-title":"Cornea"},{"key":"1219_CR52","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.jaad.2018.02.039","volume":"79","author":"HS Jeon","year":"2018","unstructured":"Jeon\u00a0HS, Choi\u00a0M, Byun\u00a0SJ et al (2018) Atopic dermatitis is not a\u00a0risk factor for keratoconus: a population-based cohort study. J\u00a0Am Acad Dermatol 79:160\u2013162","journal-title":"J Am Acad Dermatol"},{"key":"1219_CR53","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1111\/jdv.15608","volume":"33","author":"JP Thyssen","year":"2019","unstructured":"Thyssen\u00a0JP, De Bruin-Weller\u00a0MS, Paller\u00a0AS et al (2019) Conjunctivitis in atopic dermatitis patients with and without dupilumab therapy\u2014international eczema council survey and opinion. J\u00a0Eur Acad Dermatol Venereol 33:1224\u20131231","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"1219_CR54","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1007\/s00105-018-4316-1","volume":"70","author":"J Wohlrab","year":"2019","unstructured":"Wohlrab\u00a0J, Wollenberg\u00a0A, Reimann\u00a0H et al (2019) Interdisciplinary recommendations for action in dupilumab-related inflammatory eye diseases. Hautarzt 70:64\u201367","journal-title":"Hautarzt"},{"key":"1219_CR55","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.jaad.2017.08.037","volume":"78","author":"RL Gallo","year":"2018","unstructured":"Gallo\u00a0RL, Granstein\u00a0RD, Kang\u00a0S et\u00a0al (2018) Standard classification and pathophysiology of rosacea: The 2017 update by the National Rosacea Society Expert Committee. J\u00a0Am Acad Dermatol 78:148\u2013155","journal-title":"J Am Acad Dermatol"},{"key":"1219_CR56","first-page":"768","volume":"11","author":"M Reinholz","year":"2013","unstructured":"Reinholz\u00a0M, Tietze\u00a0JK, Kilian\u00a0K et\u00a0al (2013) Rosacea \u2013 S1 guideline. J\u00a0Dtsch Dermatol Ges 11:768\u2013780; 768\u2013779","journal-title":"J Dtsch Dermatol Ges"},{"key":"1219_CR57","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1097\/ICO.0b013e31802e3a54","volume":"26","author":"KE Donaldson","year":"2007","unstructured":"Donaldson\u00a0KE, Karp\u00a0CL, Dunbar\u00a0MT (2007) Evaluation and treatment of children with ocular rosacea. Cornea 26:42\u201346","journal-title":"Cornea"},{"key":"1219_CR58","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1111\/bjd.15173","volume":"176","author":"M Schaller","year":"2017","unstructured":"Schaller\u00a0M, Almeida\u00a0LM, Bewley\u00a0A et\u00a0al (2017) Rosacea treatment update: recommendations from the global ROSacea COnsensus (ROSCO) panel. Br J Dermatol 176:465\u2013471","journal-title":"Br J Dermatol"},{"key":"1219_CR59","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1097\/ICO.0b013e318254205f","volume":"32","author":"GN Foulks","year":"2013","unstructured":"Foulks\u00a0GN, Borchman\u00a0D, Yappert\u00a0M et\u00a0al (2013) Topical azithromycin and oral doxycycline therapy of meibomian gland dysfunction: a\u00a0comparative clinical and spectroscopic pilot study. Cornea 32:44\u201353","journal-title":"Cornea"},{"key":"1219_CR60","first-page":"1016","volume":"9","author":"M Zandian","year":"2016","unstructured":"Zandian\u00a0M, Rahimian\u00a0N, Soheilifar\u00a0S (2016) Comparison of therapeutic effects of topical azithromycin solution and systemic doxycycline on posterior blepharitis. Int J Ophthalmol 9:1016\u20131019","journal-title":"Int J Ophthalmol"},{"key":"1219_CR61","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.survophthal.2017.07.005","volume":"63","author":"EJ Wladis","year":"2018","unstructured":"Wladis\u00a0EJ, Adam\u00a0AP (2018) Treatment of ocular rosacea. Surv Ophthalmol 63:340\u2013346","journal-title":"Surv Ophthalmol"},{"key":"1219_CR62","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/j.1365-4632.2008.03445.x","volume":"47","author":"M Akhyani","year":"2008","unstructured":"Akhyani\u00a0M, Ehsani\u00a0AH, Ghiasi\u00a0M et\u00a0al (2008) Comparison of efficacy of azithromycin vs. doxycycline in the treatment of rosacea: a\u00a0randomized open clinical trial. Int J Dermatol 47:284\u2013288","journal-title":"Int J Dermatol"}],"container-title":["Der Ophthalmologe"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00347-020-01219-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00347-020-01219-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00347-020-01219-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T01:54:14Z","timestamp":1630461254000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00347-020-01219-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":62,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["1219"],"URL":"https:\/\/doi.org\/10.1007\/s00347-020-01219-x","relation":{},"ISSN":["0941-293X","1433-0423"],"issn-type":[{"value":"0941-293X","type":"print"},{"value":"1433-0423","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"1 September 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"Gem\u00e4\u00df den Richtlinien des Springer Medizin Verlags werden Autoren und Wissenschaftliche Leitung im Rahmen der Manuskripterstellung und Manuskriptfreigabe aufgefordert, eine vollst\u00e4ndige Erkl\u00e4rung zu ihren finanziellen und nichtfinanziellen Interessen abzugeben.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"<b>E.M.\u00a0Messmer<\/b>: A.\u00a0Finanzielle Interessen: Berater\/interner Schulungsreferent\/Gehaltsempf\u00e4nger: Alcon\/Novartis, Bayer, Domp\u00e9, Kala, Pharm-Allergan GmbH, Santen GmbH, Sun, Th\u00e9a Pharma GmbH, TRB-Chemedica AG, VISUfarma. Vortragshonorare: Alcon\/Novartis, Domp\u00e9, Pharm-Allergan GmbH, Santen GmbH, Th\u00e9a Pharma GmbH, TRB-Chemedica AG, Ursapharm, VISUfarma. \u2013 B.\u00a0Nichtfinanzielle Interessen: Ober\u00e4rztin an der Universit\u00e4ts-Augenklinik M\u00fcnchen | Mitgliedschaften: Mitglied des Gesamtpr\u00e4sidiums der DOG, Mitglied des Resorts \u201eTrockenes Auge\u201c im BVA, Corresponding Secretary EOPS (European ophthalmic pathology society), Schatzmeisterin EuDES (European Dry Eye Society).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Autoren"}},{"value":"Die vollst\u00e4ndige Erkl\u00e4rung zum Interessenkonflikt der Wissenschaftlichen Leitung finden Sie am Kurs der zertifizierten Fortbildung auf ExternalRef removed.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Wissenschaftliche Leitung"}},{"value":"erkl\u00e4rt, dass f\u00fcr die Publikation dieser CME-Fortbildung keine Sponsorengelder an den Verlag flie\u00dfen.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Der Verlag"}},{"value":"F\u00fcr diesen Beitrag wurden vom Autor keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien. F\u00fcr Bildmaterial oder anderweitige Angaben innerhalb des Manuskripts, \u00fcber die Patienten zu identifizieren sind, liegt von ihnen und\/oder ihren gesetzlichen Vertretern eine schriftliche Einwilligung vor.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Der Verlag"}}]}}